FDA.reportPublic FDA data

4 ML amisulpride 2.5 MG/ML Injection

RxCUI
2467148
RxNorm name
4 ML amisulpride 2.5 MG/ML Injection
Display name
4 ML amisulpride 2.5 MG/ML Injection
Full name
4 ML amisulpride 2.5 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BarhemsysAMISULPRIDEAcacia Pharma Ltdab23bc6e-b6a8-165f-e053-2a95a90ab1442026-06-17Warnings, Adverse reactionsExact identifier
rxcui: 2467148

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ab23bc6e-b6a8-165f-e053-2a95a90ab1444 ML amisulpride 2.5 MG/ML InjectionSCD7These highlights do not include all the information needed to use BARHEMSYS safely and effectively. See full prescribing information for BARHEMSYS. BARHEMSYS ® (amisulpride) injection, for intravenous use Initial U.S. Approval: 202020250609
ab23bc6e-b6a8-165f-e053-2a95a90ab144amisulpride 10 MG in 4 ML InjectionPSN7These highlights do not include all the information needed to use BARHEMSYS safely and effectively. See full prescribing information for BARHEMSYS. BARHEMSYS ® (amisulpride) injection, for intravenous use Initial U.S. Approval: 202020250609
ab23bc6e-b6a8-165f-e053-2a95a90ab144amisulpride 10 MG per 4 ML InjectionSY7These highlights do not include all the information needed to use BARHEMSYS safely and effectively. See full prescribing information for BARHEMSYS. BARHEMSYS ® (amisulpride) injection, for intravenous use Initial U.S. Approval: 202020250609
ab23bc6e-b6a8-165f-e053-2a95a90ab144amisulpride 2.5 MG/ML per 4 ML InjectionSY7These highlights do not include all the information needed to use BARHEMSYS safely and effectively. See full prescribing information for BARHEMSYS. BARHEMSYS ® (amisulpride) injection, for intravenous use Initial U.S. Approval: 202020250609